These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 35228665

  • 1. Germline alterations among Hispanic men with prostate cancer.
    Pan E, Shaya J, Madlensky L, Randall JM, Javier-Desloges J, Millard FE, Rose B, Parsons JK, Nielsen SM, Hatchell KE, Esplin ED, Nussbaum RL, Weise N, Murphy J, Martinez ME, McKay RR.
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):561-567. PubMed ID: 35228665
    [Abstract] [Full Text] [Related]

  • 2. Ethnic disparities among men with prostate cancer undergoing germline testing.
    Kwon DH, Borno HT, Cheng HH, Zhou AY, Small EJ.
    Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
    [Abstract] [Full Text] [Related]

  • 3. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
    Giri VN, Hartman R, Pritzlaff M, Horton C, Keith SW.
    JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082
    [Abstract] [Full Text] [Related]

  • 4. Disparate Rates of Germline Variants in Cancer Predisposition Genes in African American/Black Compared With Non-Hispanic White Individuals Between 2015 and 2022.
    Wyatt Castillo RB, Nielsen SM, Chen E, Heald B, Ellsworth RE, Esplin ED, Tomlinson GE.
    JCO Precis Oncol; 2024 Jul; 8():e2300715. PubMed ID: 38991178
    [Abstract] [Full Text] [Related]

  • 5. Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European.
    Ndugga-Kabuye MK, Issaka RB.
    Fam Cancer; 2019 Oct; 18(4):465-469. PubMed ID: 31531760
    [Abstract] [Full Text] [Related]

  • 6. Prostate cancer genetic alterations in Hispanic men.
    Arenas-Gallo C, Rhodes S, Garcia JA, Weinstein I, Prunty M, Lewicki P, Brant A, Basourakos SP, Barbieri CE, Lifschutz N, Schumacher FR, Shoag JE.
    Prostate; 2023 Sep; 83(13):1263-1269. PubMed ID: 37301735
    [Abstract] [Full Text] [Related]

  • 7. Disparities in Cancer Genetic Testing and Variants of Uncertain Significance in the Hispanic Population of South Texas.
    Soewito S, Wyatt R, Berenson E, Poullard N, Gessay S, Mette L, Marin E, Shelby K, Alvarez E, Choi BY, Aviles C, Pulido-Saldivar AM, Otto PM, Jatoi I, Ramamurthy C, Ignatius M, Kaklamani VG, Tomlinson GE.
    JCO Oncol Pract; 2022 May; 18(5):e805-e813. PubMed ID: 35544645
    [Abstract] [Full Text] [Related]

  • 8. Germline Variants in DNA Damage Repair Genes and HOXB13 Among Black Patients With Early-Onset Prostate Cancer.
    Trendowski MR, Sample C, Baird T, Sadeghpour A, Moon D, Ruterbusch JJ, Beebe-Dimmer JL, Cooney KA.
    JCO Precis Oncol; 2022 Nov; 6():e2200460. PubMed ID: 36446039
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing.
    Horton C, Hoang L, Zimmermann H, Young C, Grzybowski J, Durda K, Vuong H, Burks D, Cass A, LaDuca H, Richardson ME, Harrison S, Chao EC, Karam R.
    JAMA Oncol; 2024 Feb 01; 10(2):212-219. PubMed ID: 37924330
    [Abstract] [Full Text] [Related]

  • 10. Rare germline genetic variants and risk of aggressive prostate cancer.
    Nguyen-Dumont T, MacInnis RJ, Steen JA, Theys D, Tsimiklis H, Hammet F, Mahmoodi M, Pope BJ, Park DJ, Mahmood K, Severi G, Bolton D, Milne RL, Giles GG, Southey MC.
    Int J Cancer; 2020 Oct 15; 147(8):2142-2149. PubMed ID: 32338768
    [Abstract] [Full Text] [Related]

  • 11. Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based Testing.
    Abusamra SM, Solorzano MA, Quarles J, Luke M, Patel M, Vince R, Jiang R, Volin J, Jacobs MF, Kaffenberger SD, Salami SS, Palmbos P, Caram MEV, Hollenbeck BK, Palapattu GS, Merajver SD, Stoffel EM, Hafron J, Morgan TM, Reichert ZR.
    Urol Pract; 2025 Jan 15; 12(1):63-72. PubMed ID: 39383006
    [Abstract] [Full Text] [Related]

  • 12. Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.
    Cheng HH, Sokolova AO, Gulati R, Bowen D, Knerr SA, Klemfuss N, Grivas P, Hsieh A, Lee JK, Schweizer MT, Yezefski T, Zhou A, Yu EY, Nelson PS, Montgomery B.
    JCO Precis Oncol; 2023 Jan 15; 7():e2200104. PubMed ID: 36623239
    [Abstract] [Full Text] [Related]

  • 13. Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center.
    Tatineni S, Tarockoff M, Abdallah N, Purrington KS, Assad H, Reagle R, Petrucelli N, Simon MS.
    Cancer Med; 2022 Mar 15; 11(6):1465-1473. PubMed ID: 35040284
    [Abstract] [Full Text] [Related]

  • 14. Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants.
    Mezina A, Philips N, Bogus Z, Erez N, Xiao R, Fan R, Olthoff KM, Reddy KR, Samadder NJ, Nielsen SM, Hatchell KE, Esplin ED, Rustgi AK, Katona BW, Hoteit MA, Nathanson KL, Wangensteen KJ.
    JCO Precis Oncol; 2021 Mar 15; 5():. PubMed ID: 34250406
    [Abstract] [Full Text] [Related]

  • 15. Prostate cancer upgrading and adverse pathology in Hispanic men undergoing radical prostatectomy.
    Hougen HY, Iakymenko OA, Punnen S, Ritch CR, Nahar B, Parekh DJ, Kryvenko ON, Gonzalgo ML.
    World J Urol; 2022 Aug 15; 40(8):2017-2023. PubMed ID: 35689106
    [Abstract] [Full Text] [Related]

  • 16. Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing.
    Giri VN, Hegarty SE, Hyatt C, O'Leary E, Garcia J, Knudsen KE, Kelly WK, Gomella LG.
    Prostate; 2019 Mar 15; 79(4):333-339. PubMed ID: 30450585
    [Abstract] [Full Text] [Related]

  • 17. Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.
    Vlaming M, Bleiker EMA, van Oort IM, Kiemeney LALM, Ausems MGEM.
    BMC Cancer; 2022 Dec 30; 22(1):1365. PubMed ID: 36581909
    [Abstract] [Full Text] [Related]

  • 18. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
    Isaacsson Velho P, Silberstein JL, Markowski MC, Luo J, Lotan TL, Isaacs WB, Antonarakis ES.
    Prostate; 2018 Apr 30; 78(5):401-407. PubMed ID: 29368341
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of universal germline testing for men with prostate cancer in an Australian tertiary center.
    Crumbaker M, Wong J, Joshua AM, Spigelman AD.
    Asia Pac J Clin Oncol; 2019 Aug 30; 15(4):257-261. PubMed ID: 31012270
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.